273 related articles for article (PubMed ID: 24352761)
1. Clinical significance of microRNA-183/Ezrin axis in judging the prognosis of patients with osteosarcoma.
Mu Y; Zhang H; Che L; Li K
Med Oncol; 2014 Feb; 31(2):821. PubMed ID: 24352761
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma.
Wang G; Shen N; Cheng L; Lin J; Li K
Tumour Biol; 2015 Sep; 36(10):7891-5. PubMed ID: 25953260
[TBL] [Abstract][Full Text] [Related]
3. Upregulated expression of microRNA-214 is linked to tumor progression and adverse prognosis in pediatric osteosarcoma.
Wang Z; Cai H; Lin L; Tang M; Cai H
Pediatr Blood Cancer; 2014 Feb; 61(2):206-10. PubMed ID: 24038809
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin.
Zhu J; Feng Y; Ke Z; Yang Z; Zhou J; Huang X; Wang L
Am J Pathol; 2012 Jun; 180(6):2440-51. PubMed ID: 22525461
[TBL] [Abstract][Full Text] [Related]
5. Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma.
Li RZ; Wang LM
World J Surg Oncol; 2016 May; 14():150. PubMed ID: 27193084
[TBL] [Abstract][Full Text] [Related]
6. Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma.
Zeng H; Zhang Z; Dai X; Chen Y; Ye J; Jin Z
Pathol Oncol Res; 2016 Apr; 22(2):253-60. PubMed ID: 26183062
[TBL] [Abstract][Full Text] [Related]
7. Combined microRNA-340 and ROCK1 mRNA profiling predicts tumor progression and prognosis in pediatric osteosarcoma.
Cai H; Lin L; Cai H; Tang M; Wang Z
Int J Mol Sci; 2014 Jan; 15(1):560-73. PubMed ID: 24398981
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.
Xu SH; Yang YL; Han SM; Wu ZH
World J Surg Oncol; 2014 Jun; 12():195. PubMed ID: 24969351
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of microRNA-223/epithelial cell transforming sequence 2 signaling in patients with osteosarcoma.
Zhang H; Yin Z; Ning K; Wang L; Guo R; Ji Z
Hum Pathol; 2014 Jul; 45(7):1430-6. PubMed ID: 24784921
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of microRNA-19a predicts a poor prognosis in patients with osteosarcoma.
Zou P; Ding J; Fu S
Pathol Res Pract; 2017 Mar; 213(3):194-198. PubMed ID: 28214202
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma.
Li X; Yang H; Tian Q; Liu Y; Weng Y
Neoplasma; 2014; 61(4):453-60. PubMed ID: 24645838
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of microRNA-133b and microRNA-206 expression predict prognosis in patients with osteosarcoma.
Zhang C; Yao C; Li H; Wang G; He X
Int J Clin Exp Pathol; 2014; 7(7):4194-203. PubMed ID: 25120799
[TBL] [Abstract][Full Text] [Related]
13. microRNA-96 acts as a tumor suppressor gene in human osteosarcoma via target regulation of EZRIN.
Yao Q; Pei Y; Zhang X; Xie B
Life Sci; 2018 Jun; 203():1-11. PubMed ID: 29656060
[TBL] [Abstract][Full Text] [Related]
14. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients.
Chen K; Pan G
Pathol Res Pract; 2019 Dec; 215(12):152686. PubMed ID: 31711673
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.
Song QC; Shi ZB; Zhang YT; Ji L; Wang KZ; Duan DP; Dang XQ
Oncol Rep; 2014 Mar; 31(3):1263-70. PubMed ID: 24452597
[TBL] [Abstract][Full Text] [Related]
17. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
Lozano Calderón SA; Garbutt C; Kim J; Lietz CE; Chen YL; Bernstein K; Chebib I; Nielsen GP; Deshpande V; Rubio R; Wang YE; Quackenbush J; Delaney T; Raskin K; Schwab J; Cote G; Spentzos D
Clin Orthop Relat Res; 2019 Sep; 477(9):2114-2126. PubMed ID: 31389890
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the microRNA-29 family in patients with primary osteosarcomas.
Hong Q; Fang J; Pang Y; Zheng J
Med Oncol; 2014 Aug; 31(8):37. PubMed ID: 25015394
[TBL] [Abstract][Full Text] [Related]
19. Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas.
Salas S; Bartoli C; Deville JL; Gaudart J; Fina F; Calisti A; Bollini G; Curvale G; Gentet JC; Duffaud F; Figarella-Branger D; Bouvier C
Virchows Arch; 2007 Dec; 451(6):999-1007. PubMed ID: 17786474
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of microRNA-26a and up-regulation of microRNA-27a contributes to aggressive progression of human osteosarcoma.
Taheriazam A; Bahador R; Karbasy SH; Jamshidi SM; Torkaman A; Yahaghi E; Shakeri M
Diagn Pathol; 2015 Sep; 10():166. PubMed ID: 26377680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]